Frank Takkinen
Stock Analyst at Lake Street
(0.57)
# 3,788
Out of 5,152 analysts
707
Total ratings
36.5%
Success rate
-1.8%
Average return
Main Sectors:
Stocks Rated by Frank Takkinen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NSPR InspireMD | Reiterated: Buy | $4 → $3 | $0.6856 | +337.57% | 18 | Nov 18, 2026 | |
| NPCE NeuroPace | Reiterated: Buy | $20 → $13 | $8.22 | +58.15% | 50 | Nov 13, 2026 | |
| TLSI TriSalus Life Sciences | Reiterated: Buy | $8 → $6 | $2.45 | +144.90% | 24 | Nov 11, 2026 | |
| AXGN Axogen | Reiterated: Buy | $58 → $60 | $56.95 | +5.36% | 18 | Nov 10, 2026 | |
| CVRX CVRx, Inc. | Reiterated: Hold | $3.5 → $1.5 | $0.604 | +148.34% | 49 | Nov 6, 2026 | |
| RCEL AVITA Medical | Reiterated: Buy | $12 → $20 | $16.83 | +18.84% | 15 | Nov 6, 2026 | |
| SGHT Sight Sciences | Reiterated: Buy | $12 → $14 | $10.77 | +29.99% | 29 | Nov 5, 2026 | |
| COCH Envoy Medical | Reiterated: Buy | $25 | $6.73 | +271.47% | 19 | Oct 27, 2026 | |
| ELUT Elutia | Reiterated: Buy | $5 | $0.83 | +502.41% | 34 | Oct 5, 2026 | |
| MDXG MiMedx Group | Reiterated: Buy | $7 | $3.18 | +120.13% | 11 | Oct 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $7.71 | +224.25% | 52 | Sep 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 | $0.7801 | +156.38% | 43 | Sep 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.5 | $0.5449 | +358.80% | 21 | Sep 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $17.05 | +193.26% | 6 | Sep 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $14.33 | +74.46% | 15 | Sep 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $1.85 | +440.54% | 1 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $35 | $32.73 | +6.94% | 4 | Aug 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $4.85 | +168.04% | 19 | Aug 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $21 → $15 | $11.16 | +34.41% | 2 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $3 | $0.9461 | +217.09% | 39 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $18.54 | +142.72% | 37 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $3.45 | +131.88% | 35 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 | $82.31 | +45.79% | 20 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $2.69 | +48.70% | 18 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $11.32 | +112.01% | 5 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $8.01 | +187.14% | 5 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.52 | +163.16% | 7 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 → $135 | $75.58 | +78.62% | 12 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $15 | $5.21 | +187.91% | 9 | Jan 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $150 | $58.11 | n/a | 28 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.5 | $2.49 | n/a | 18 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $3.10 | n/a | 11 | Jul 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.32 | n/a | 6 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22.81 → $19.96 | $9.83 | n/a | 9 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $12 | $0.0532 | n/a | 3 | Feb 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1 | $0.7801 | n/a | 4 | Sep 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $10 | $3.59 | n/a | 7 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5.72 | $0.16 | n/a | 1 | Apr 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $6 → $10 | $0.0001 | n/a | 3 | Mar 31, 2022 |
InspireMD
Nov 18, 2026
Reiterated: Buy
Price Target: $4 → $3
Current: $0.6856
Upside: +337.57%
NeuroPace
Nov 13, 2026
Reiterated: Buy
Price Target: $20 → $13
Current: $8.22
Upside: +58.15%
TriSalus Life Sciences
Nov 11, 2026
Reiterated: Buy
Price Target: $8 → $6
Current: $2.45
Upside: +144.90%
Axogen
Nov 10, 2026
Reiterated: Buy
Price Target: $58 → $60
Current: $56.95
Upside: +5.36%
CVRx, Inc.
Nov 6, 2026
Reiterated: Hold
Price Target: $3.5 → $1.5
Current: $0.604
Upside: +148.34%
AVITA Medical
Nov 6, 2026
Reiterated: Buy
Price Target: $12 → $20
Current: $16.83
Upside: +18.84%
Sight Sciences
Nov 5, 2026
Reiterated: Buy
Price Target: $12 → $14
Current: $10.77
Upside: +29.99%
Envoy Medical
Oct 27, 2026
Reiterated: Buy
Price Target: $25
Current: $6.73
Upside: +271.47%
Elutia
Oct 5, 2026
Reiterated: Buy
Price Target: $5
Current: $0.83
Upside: +502.41%
MiMedx Group
Oct 1, 2026
Reiterated: Buy
Price Target: $7
Current: $3.18
Upside: +120.13%
Sep 30, 2026
Reiterated: Buy
Price Target: $25
Current: $7.71
Upside: +224.25%
Sep 30, 2026
Reiterated: Buy
Price Target: $2
Current: $0.7801
Upside: +156.38%
Sep 28, 2026
Reiterated: Buy
Price Target: $2.5
Current: $0.5449
Upside: +358.80%
Sep 28, 2026
Reiterated: Buy
Price Target: $50
Current: $17.05
Upside: +193.26%
Sep 22, 2026
Reiterated: Buy
Price Target: $25
Current: $14.33
Upside: +74.46%
Sep 1, 2026
Initiated Coverage: Buy
Price Target: $10
Current: $1.85
Upside: +440.54%
Aug 26, 2026
Reiterated: Hold
Price Target: $35
Current: $32.73
Upside: +6.94%
Aug 25, 2026
Reiterated: Buy
Price Target: $13
Current: $4.85
Upside: +168.04%
Aug 14, 2026
Rated: Buy
Price Target: $21 → $15
Current: $11.16
Upside: +34.41%
Aug 12, 2026
Reiterated: Buy
Price Target: $4 → $3
Current: $0.9461
Upside: +217.09%
Aug 7, 2026
Reiterated: Buy
Price Target: $45
Current: $18.54
Upside: +142.72%
Aug 6, 2026
Reiterated: Buy
Price Target: $8
Current: $3.45
Upside: +131.88%
Aug 3, 2026
Reiterated: Buy
Price Target: $120
Current: $82.31
Upside: +45.79%
Jul 30, 2026
Reiterated: Buy
Price Target: $4
Current: $2.69
Upside: +48.70%
Jul 14, 2026
Reiterated: Buy
Price Target: $24
Current: $11.32
Upside: +112.01%
May 26, 2026
Reiterated: Buy
Price Target: $23
Current: $8.01
Upside: +187.14%
May 21, 2026
Reiterated: Buy
Price Target: $4
Current: $1.52
Upside: +163.16%
May 6, 2026
Reiterated: Buy
Price Target: $110 → $135
Current: $75.58
Upside: +78.62%
Jan 23, 2026
Reiterated: Buy
Price Target: $20 → $15
Current: $5.21
Upside: +187.91%
Aug 27, 2025
Reiterated: Buy
Price Target: $150
Current: $58.11
Upside: n/a
Aug 9, 2024
Reiterated: Buy
Price Target: $2.5
Current: $2.49
Upside: n/a
Jul 22, 2024
Reiterated: Buy
Price Target: $10
Current: $3.10
Upside: n/a
May 15, 2024
Reiterated: Buy
Price Target: $4
Current: $1.32
Upside: n/a
Nov 3, 2023
Reiterated: Buy
Price Target: $22.81 → $19.96
Current: $9.83
Upside: n/a
Feb 14, 2023
Reiterated: Buy
Price Target: $4 → $12
Current: $0.0532
Upside: n/a
Sep 29, 2022
Reiterated: Buy
Price Target: $1
Current: $0.7801
Upside: n/a
May 11, 2022
Reiterated: Buy
Price Target: $14 → $10
Current: $3.59
Upside: n/a
Apr 5, 2022
Initiated Coverage: Buy
Price Target: $5.72
Current: $0.16
Upside: n/a
Mar 31, 2022
Downgraded: Hold
Price Target: $6 → $10
Current: $0.0001
Upside: n/a